Reconstitution of circulating lymphocyte subsets after treatment with cladribine tablets in the 96-week CLARITY study in relapsing-remitting multiple sclerosis

被引：0
|
作者：
Sorensen, P. Soelberg
Rieckmann, P.
Comi, G.
Cook, S.
Giovannoni, G.
Rammohan, K.
Vermersch, P.
Bock, D.
Hamlett, A.
Fevr, T.
Musch, B.
Greenberg, S.
机构：
[1] Copenhagen Univ Hosp, Copenhagen, Denmark
[2] Bamberg Hosp, Bamberg, Germany
[3] Univ Vita Salute San Raffaele, Milan, Italy
[4] Univ Med & Dent, Newark, NJ USA
[5] Barts & London Queen Marys Sch Med & Dent, London, England
[6] Ohio State Univ, Columbus, OH 43210 USA
[7] Univ Lille Nord France, Lille, France
[8] Merck Serono SA, Geneva, Switzerland
来源：
JOURNAL OF NEUROLOGY | 2010年 / 257卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P442
引用
收藏
页码：S143 / S143
页数：1
相关论文
共 50 条
  • [41] Consistent Efficacy of Cladribine Tablets across Multiple Sclerosis and Patient Characteristics, in the Double-Blind, 96-Week CLARITY Study
    Rammohan, Kottil
    Comi, Giancarlo
    Cook, Stuart
    Giovannoni, Gavin
    Rieckmann, Peter
    Sorensen, Per Soelberg
    Vermersch, Patrick
    Chang, Peter
    Hamlett, Anthony
    Verjee, Rehan
    Musch, Bruno
    Greenberg, Steven
    NEUROLOGY, 2010, 74 (09) : A166 - A167
  • [42] CLARITY: an analysis of severity and frequency of relapses in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets or placebo
    Schippling, S.
    Sormani, M. P.
    De Stefano, N.
    Giovannoni, G.
    Galazka, A.
    Keller, B.
    Alexandri, N.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 258 - 259
  • [43] CLARITY: An Analysis of Severity and Frequency of Relapses in Patients with Relapsing-remitting Multiple Sclerosis Treated with Cladribine Tablets or Placebo
    Schippling, S.
    Sormani, M. P.
    De Stefano, N.
    Giovannoni, G.
    King, J.
    Galazka, A.
    Keller, B.
    Alexandri, N.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 466 - 467
  • [44] Safety and Efficacy of Oral Cladribine in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the 96 Week Phase IIIb Extension Trial to the CLARITY Study
    Giovannoni, Gavin
    Comi, Giancarlo
    Cook, Stuart
    Rammohan, Kottil
    Rieckmann, Peter
    Soelberg-Sorensen, Per
    Vermersch, Patrick
    Hamlett, Anthony
    Scaramozza, Matthew
    Lachenal, Nathalie
    NEUROLOGY, 2013, 80
  • [45] The Effect Of Cladribine Tablets In Patients With Relapsing-remitting Multiple Sclerosis Who Had Evidence Of Disease Activity In CLARITY
    Greenberg, B. M.
    Rammohan, K.
    Aldridge, J.
    Lebson, L. A.
    Dangond, F.
    Giovannoni, G.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 50 - 50
  • [46] Rapid and sustained efficacy with cladribine tablet treatment in relapsing-remitting multiple sclerosis (RRMS): results from the CLARITY study, a 96-week, phase III, double-blind, placebo-controlled trial
    Vermersch, P.
    Comi, G.
    Cook, S.
    Giovannoni, G.
    Rammohan, K.
    Rieckmann, P.
    Soelberg-Sorensen, P.
    Chang, P.
    Hamlett, A.
    Musch, B.
    Verjee, R.
    Greenberg, S.
    JOURNAL OF NEUROLOGY, 2009, 256 : S244 - S245
  • [47] Oral cladribine in relapsing-remitting multiple sclerosis: study design of the 2-year, Phase IIIb CLARITY (CLAdRIbine tablets Treating multiple sclerosis orallY) extension study
    Giovannoni, G.
    Cook, S.
    Greenberg, S.
    Chang, P.
    Comi, G.
    Rieckmann, P.
    Sorensen, P. Soelberg
    Vermersch, P.
    JOURNAL OF NEUROLOGY, 2008, 255 : 206 - 206
  • [48] Cognitive improvements in ocrelizumab-treated patients with relapsing-remitting multiple sclerosis: 96-week CASTING study data
    Benedict, R. H.
    Comi, G.
    Oreja-Guevara, C.
    Siva, A.
    Van Wijmeersch, B.
    Wiendl, H.
    Buffels, R.
    Kuenzel, T.
    Vermersch, P.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 392 - 393
  • [49] Effect of cladribine tablets on brain atrophy rates in patients with relapsing-remitting multiple sclerosis (RRMS): exploratory analysis of the CLARITY study
    de Stefano, N.
    Giorgio, A.
    Battaglini, M.
    Giovannoni, G.
    Hicking, C.
    Dangond, F.
    Sormani, M. P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 532 - 532
  • [50] Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
    Giovannoni, Gavin
    Sorensen, Per Soelberg
    Cook, Stuart
    Rammohan, Kottil
    Rieckmann, Peter
    Comi, Giancarlo
    Dangond, Fernando
    Adeniji, Abidemi K.
    Vermersch, Patrick
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (12) : 1594 - 1604
12345